Tetramethylenedisulfotetramine (tetramine, TETS, TMDT) is a seizure-producing neurotoxic chemical formed by the condensation of sulfamide and formaldehyde. Serendipitously discovered through an occupational exposure in 1949, it was promoted as a rodenticide but later banned worldwide due to its danger to human health. However, exceptional activity of the agent against rodent pests resulted in its clandestine manufacture with large numbers of inadvertent, intentional, and mass poisonings, which continue to this day. Facile synthesis, extreme potency, persistence, lack of odor, color, and taste identify it as an effective food adulterant and potential chemical agent of terror. No known antidote or targeted treatment is currently available. In this review we examine the origins of tetramethylenedisulfotetramine, from its identification as a neurotoxicant 70 years ago, through early research, to the most recent findings including the risk it poses in the post-911 world. Included is the information known regarding its in vitro pharmacology as a GABA A receptor channel antagonist, the toxic syndrome it produces in vivo, and its effect upon vulnerable populations. We also summarize the available information about potential therapeutic countermeasures and treatment strategies as well as the contribution of clinical development of TMDT poisoning to our understanding of epileptogenesis. Finally we identify gaps in our knowledge and suggest potentially fruitful directions for continued research on this dangerous, yet intriguing compound.
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A contemporary U.S. appearance of tetramethylenedisulfotetramine
In May of 2002, a 15-month-old girl presented at an emergency department in New York City with convulsive status epilepticus. According to her parents, she came in contact with a rodenticide powder that they had brought from the People's Republic of China and applied to a corner in their kitchen. The child's seizures were particularly difficult to control, occurring at high frequency for 4 h despite aggressive pharmacotherapy with lorazepam, phenobarbital, and pyridoxine. While continued phenobarbital therapy provided some measure of control, it would be more than 2 weeks before the infant could be discharged, at that time displaying absence seizures and multiple neurological deficits (Barrueto Jr. et al., 2003) . As no ingredients were listed on the rodenticide package, the identity of the active agent remained elusive, despite testing for likely rodenticides. It wouldn't be until 4 months after the incident when a hint from a poisoning report in China suggested that the offending substance was tetramethylenedisulfotetramine (tetramine, TETS, here TMDT; CAS #80-12-6, Fig. 1 ). Gas chromatography-mass spectroscopy (GC-MS) analysis of the rodenticide powder confirmed this fact and revealed to the City of New York and the Centers for Disease Control and Prevention (CDC) that this agent that was regularly poisoning thousands in China had strayed from its borders and now claimed a victim in the U.S. Soon, TMDT would be recognized by the CDC and the newly created 
Brief tetramethylenedisulfotetramine (TMDT) history
TMDT was not a new poison, nor did this incident mark its first entry into the U.S. First identified by Audrieth and colleagues (Audrieth et al., 1940) after the initial synthesis of Wood and Battye (Wood and Battye, 1933) , TMDT (Fig. 1 ) is a synthetic polyhedral organic compound related to adamantane. This agent's toxic actions were serendipitously discovered from a mysterious occupational health incident at a German upholstery factory soon after the Second World War (Hagen, 1950; Hecht and Henecka, 1949) . Workers experienced headache, nausea, vomiting, and seizures, as well as other neurological and psychological disturbances. The factory obtained surplus fabric from the war manufactured by Farbwerke Bayer -Crinex™, a brand of rayon that was made fire resistant for the German Luftwaffe by impregnation with sulfamide and formaldehyde. Experiments in mice indicated that airborne fibers from this material could produce violent seizures, namely clonic and tonic-clonic, and death within 2 h. None of the individual ingredients of the material, the Crinex, sulfamide, or formaldehyde alone could elicit the same response, yet liquid extraction of the fabric yielded a compound that recapitulated the toxicity when injected into mice (Hagen, 1950; Hecht and Henecka, 1949) . The isolated compound, a condensation product of 1 part sulfamide, 2 parts formaldehyde, was determined to be TMDT, a novel and highly stable poison, producing lethality in mice at 0.15-0.2 mg/kg when subcutaneously administered (Hecht and Henecka, 1949) . Lethal effects in guinea pigs, rabbits, cats, and dogs were within the same order of magnitude to that in mice (Hecht and Henecka, 1949) .
TMDT was first introduced into the U.S. and the international market after Bayer submitted a U.S. patent on the chemical, which promoted it as a rodenticide, provided special bait recipes and compared it favorably to the commonly used strychnine, a bitter but much less potent substance than their new discovery (Hecht et al., 1953) . In 1953, it became a candidate in screening experiments by the Forest Service to identify agents effective in protecting tree seeds broadcast to reforest areas previously logged for lumber or lost by fire. The ideal agent, when used as a coating on tree seeds, would act as a deterrent to rodents and allow uninhibited growth of seedlings. TMDT was one of three agents identified from a multi-tiered screen of over 4500 compounds to meet the suitable criteria for effectiveness as a rodent repellent for seed coating. An unnatural coloring was found to discourage feeding by birds and acted as a cue to rodents of the adverse effects the treated seeds would produce (Spencer et al., 1954) . Initial field testing showed much promise, protecting seeds and the resulting seedlings, due to translocation of the poison throughout the plant. However, later inconsistency in field performance reduced enthusiasm for the agent in favor of endrin, and hazards associated with its manufacture prompted the original supplier to discontinue production of the chemical (Dimock, 1957) . TMDT thus never became commercially available in the U.S. (Radwan, 1963) .
Abundance of poisonings in China
Acute pesticide (herbicide, insecticide, or rodenticide) poisoning is a serious public health issue worldwide for which there are no reliable figures on the extent of morbidity and mortality. The causes vary by country. However, in large rural populations, easy access to highly toxic pesticides otherwise banned by industrialized countries, and difficulty in enforcing the regulations are factors consistent with the problem in mainland China (Thundiyil et al., 2008) . In China, pesticides play the leading role in death from chemical exposures (Li et al., 2004) . Surveys from several cities and provinces indicate that non-occupational, rather than occupational, pesticide poisoning accounts for the great majority of reported incidents (Chen et al., 2005 , Jiang et al., 2013 , Liu et al., 2014 , Yu et al., 2015 , Zhao and Liu, 2012 . It should be emphasized that many of these poisonings are deliberate rather than accidental. TMDT is one of the most toxic and deadly pesticides in China (Jiang et al., 2013; Yu et al., 2015; Zhou et al., 2011) . A survey of TMDT intoxication in Chinese journals yielded over 14,000 poisoning cases with 932 deaths between January 1991 and December 2010 . The common route of exposure is orally through food and drink (Li et al., 2014) . Victims may present with headache, fatigue, dizziness, paresthesia, nausea, vomiting, foaming at the mouth, and twitching, and progress to partial or generalized seizures and status epilepticus from which death may result (Deng et al., 2012; Li et al., 2014; Lu et al., 2008; Whitlow et al., 2005) . Persistent neurological sequelae such as epilepsy, memory and learning difficulties, or psychiatric disturbances are not uncommon (Barrueto Jr. et al., 2003; Intusoma and Sornsrivichai, 2009; Li et al., 2012) . In a survey of 361 survivors of TMDT poisoning, more than half continued to have spontaneous seizures 2.3-9 years afterwards (ergo true epilepsy), including some victims who did not initially experience seizures (Deng et al., 2012) . Apparently, a high water mark in TMDT poisoning was reached with the "Nanjing Incident" on September 14, 2002 where a jealous shop owner adulterated the foodstuffs in his competitor's snack bar. Over 300 people were poisoned resulting in 42 deaths, all of them children (Croddy, 2004; Li et al., 2014; Wu and Sun, 2004) . The Chinese government responded with new regulations, implemented in 2003, to reduce poisoning incidents and address the safety risks of this already banned agent. Included was cooperation between the relevant national ministries and law enforcement, in collaboration with local governments (Li et al., 2014) . Subsequently, 23.3 metric tons of TMDT were captured by the State Administration for Industry and Commerce in August of 2003 (Wu and Sun, 2004) , and there was a decrease in poisonings by this agent (Li et al., 2014) . However, a 2011 report from China still described TMDT ingestion as a common method of intentional and unintentional poisoning (Zhou et al., 2011) . TMDT remains responsible for numerous poisonings and deaths, including occasional high profile reports of mass casualties. Recent examples include one in Dongguan, southeast China, where a man, disillusioned with society, injected TMDT into cartons of a tea drink at several supermarkets (Choi, 2015) . One person was killed and four others hospitalized. At a restaurant in Shaanxi Province, northwest China, 39 people, including 11 children, fell ill from a cold noodle dish that was found to be contaminated with TMDT (Xinhua News Service, 2015) . Also noteworthy are two incidents where children were specifically targeted in efforts by one kindergarten to tarnish the reputation of a competing one ("kindergarten wars"). In Hebei Province, two young girls consumed TMDTlaced yogurt drink prepared by the head teacher of a rival institution (Moore, 2013) , and in Yunnan Province, a rival school's manager poisoned the water supply of another school, leading to hospitalization of 76 children and killing two of them (Bloom, 2014) .
Incidents such as these, and the unique characteristics of TMDT, raise concerns that it may effectively be used as a chemical agent of terror (Jett and Yeung, 2010) . Indeed, TMDT possesses key features of a Fig. 1 . Chemical structure of tetramethylenedisulfotetramine (tetramine, TETS, TMDT), CAS# 80-12-6, IUPAC Name 2,6-Dithia-1, 3,5,7-tetraaza-tricyclo [3.3.1.1 3,7 ]decane 2,2,6,6-tetraoxide.
M. Lauková, et al. Neurobiology of Disease 133 (2020) 104491 terrorist chemical weapon, including facile synthesis from readily obtained starting materials, high potency, with an estimated human lethal dose of 0.1 mg/kg, lack of color or odor, stability as an adulterant in food and drink, and persistent action after ingestion (Croddy, 2004) .
Mechanism of action of TMDT
Early studies revealed that TMDT has analeptic properties (Haskell and Voss, 1957; Richter, 1954) , increasing respiratory rate and amplitude, and effectively antagonizing the actions of depressant drugs such as the barbiturates, similar to the effects of picrotoxin or pentylenetetrazole (Hahn, 1960) . Voss and Colleagues, having obtained TMDT from the U.S. Forest Service, characterized its toxicological properties in a variety of experimental models. TMDT was absorbed from the upper respiratory tract and oral cavity but not through intact skin. They found no major activity of TMDT upon autonomic and peripheral nerves or skeletal muscle. Convulsions were found to be centrally controlled and dependent especially upon the brainstem activity, as demonstrated in decerebrate mammalian models. TMDT also had no direct effect upon intestinal or bladder motility, nor spleen or kidney size in spinal dogs (Haskell and Voss, 1957) . Considering the occupational hazards TMDT could pose in reforestation efforts, the group decided to test centrally acting sedative compounds as pharmacological antagonists of TMDT (Voss et al., 1961) . Pretreatment of mice with sodium bromide or long acting barbiturates increased latency and reduced the severity of TMDT-induced seizures, leading to improved survival over a 5-day observation period. Conversely, neither urethane, chloral hydrate, sodium pentobarbital, nor trimethadione were able to offer satisfactory protection in their hands. The authors attributed these latter results to the shorter acting nature of the treatments, as opposed to the observed long duration of action of TMDT in the experimental animals (Voss et al., 1961) .
TMDT is a GABA channel antagonist
It would take 20 years before a clearer understanding of the locus of action of TMDT would emerge. Evidence for the essential criteria to identify gamma-aminobutyric acid (GABA) as a central neurotransmitter, i.e., synthesis, storage, release, postsynaptic action, and specific reuptake, was available during the early 1970s, as summarized by Curtis and Johnston (1974) . These authors also predicted that TMDT, based upon their experimental observations and similarities in action to bicuculline and picrotoxinin, was likely an antagonist of GABA activity. Using a rat superior cervical ganglion preparation, Bowery et al. (1975) found that TMDT concentration-dependently antagonized the depolarizing actions of GABA, while not affecting the actions of the cholinomimetic agent, carbachol. The action of TMDT was reversed by washout of the preparation. In contrast to methyl-bicuculline which shifted the GABA dose-response curve to the right, TMDT reduced the maximal response to GABA, suggesting a noncompetitive mechanism of antagonism. These investigators suggested that TMDT might occlude the GABA A receptor-operated channel to produce its effect. The group subsequently (Bowery and Dray, 1978) demonstrated that pentobarbital could reverse the actions of TMDT, as well as those of picrotoxin (PTX), bicuculline, and isopropylbicyclophospate. In the cuneate nucleus of urethane-anesthetized rats, Collins and Hill (1975) found that intravenous administration of TMDT could antagonize the actions of microiontophoretically applied GABA, as well as of glycine. Three compounds structurally related to TMDT were without effect in this preparation. Using a crustacean model (Hermit cab neuromuscular junction), Large (1975) confirmed a dose-dependent, noncompetitive, and reversible action of TMDT, similar to the effects of PTX.
The use of radioligand binding techniques greatly aided in our understanding of GABAergic pharmacology. For instance, while PTX inhibited GABA synapses, it lacked the ability to displace 3 H-GABA specific binding, consistent with a noncompetitive mode of inhibition. The question then was, where did PTX bind? Using the radioligand, 3 H-dihydropicrotoxinin, Ticku et al. (1978) discovered a specific, reversible and saturable binding site in rat brain, distinct from but tracking with the GABA binding site, and with which naturally occurring antagonists of GABA A receptor activity, picrotoxinin and tutin, bound with high affinity. Further studies revealed that cage convulsants like bicyclophosphates and TMDT could displace 3 H-dihydropicrotoxinin specifically, and with high affinity (Ticku and Olsen, 1979) , suggesting that their convulsant effects are due to interaction with the GABA A receptorregulated chloride channel. New high-affinity radioligands with lower nonspecific binding now exist, allowing for improved accuracy in estimating binding constants ). The GABA A receptor has a pentameric structure, analogous to the nicotinic acetylcholine receptor, and consists of, most commonly, α, β, and γ subunits, with additional δ, ε, π, θ, and ρ subunits found less abundantly in the receptor complexes. Many variants of the subunits exist, including splice variants from a single gene, allowing for a great heterogeneity in GABA A receptor composition with functional differences in mammalian brain. However, the most common variant in the adult brain is formed by two α1 subunits, two β2 subunits, and one γ2 subunit (Sieghart and Sperk, 2002 (2001) discovered a key difference between the pharmacological behavior of TMDT and picrotoxinin. The agents displayed similar affinities for GABA A receptors in human cortical membranes and α1β3γ2 subunit-containing recombinant receptors; they also had similar potencies for inhibition of GABA-stimulated chloride flux from rat cerebral cortex vesicles (Obata et al., 1988) . However, while picrotoxinin displayed highest affinity for a recombinant GABA A pentameric receptor formed of β3 subunits, TMDT was unable to displace 3 H-EBOB from this receptor [This homopentamer displays close similarity to the housefly GABA A receptor , RDL, for which TMDT also has extremely low affinity (Deng et al., 1991) ]. This result clearly showed that, despite their pharmacological similarities, distinct differences exist in the affinities of these two agents for some GABA A receptor variants. Indeed, Palmer and Casida (1988) segregated GABA A channel antagonists into two groups, Type A (PTX and cage convulsants with large substituents or a more extended structure) and Type B (more compact cage convulsants, including TMDT), based upon their different binding properties and species selectivities. More recently, to better understand the behavior of TMDT binding relative to other noncompetitive GABA A receptor antagonists, Zhao et al. (2014) applied accelerator mass spectrometry to study the binding of 14 C-TMDT and 3 H-EBOB (a Type A agent) and their displacement by 16 Type A and Type B agents in rat brain membranes.
14 C-TMDT and 3 H-EBOB binding were similarly inhibited by this series of GABA A receptor blocking agents suggesting that the two radioligands are binding to comparable sites. In fact, unlabeled TMDT displaced either radioligand with identical potency. Molecular dynamics simulations of the binding to an α1β2γ2 GABA A receptor model predicted partially overlapping sites for all 16 agents tested. Importantly, the predicted interactions with the various subunits differed, with TMDT making most of its contacts to the α1 and γ2 subunits and EBOB binding to a much greater extent to the β2 subunit. Furthermore, TMDT binding was polar in nature while that of EBOB was strongly hydrophobic. In summary, Type A compounds rely upon hydrophobic interactions with GABA A receptor amino acid residues and are more likely to be potent insecticides, whereas Type B compounds, which exhibit some polar interactions, are more toxic in vertebrate models. The physicochemical properties of TMDT differ greatly from most of the known ligands for the GABA A receptor pore, and this compound appears to rely almost exclusively upon polar interactions, resulting in a 300-500-fold selective toxicity for mammals over insects (Zhao et al., 2014) .
With the demonstration of the unique binding characteristics of TMDT and the basis for its selective toxicity relative to other GABA A receptor antagonists, one may be prompted to ask the following: How might this agent differentially perform in the mammalian brain with subunit heterogeneity yielding a large number of GABA A receptor variants? Is there a corresponding spectrum of affinities of TMDT for these individual variants? In an attempt to shed light on these questions, Pressly et al. (2018) provided an extensive survey of the affinities of TMDT, relative to picrotoxinin (note: PTX is an equimolar mixture of picrotoxinin and picrotin, the former being the more potent), for 13 different GABA A receptor variants. This was accomplished by expressing various human α (1, 2), β (1, 3, rat β2), γ (1, 2 L variant), or δ combinations in mammalian cells (COS-7, L-929, or L-tk) and performing whole cell patch clamp experiments to evaluate the comparative ability of the two agents to antagonize the GABA A receptor-gated current. While activity against α1β2γ2L and α1β3γ2L was equivalent in terms of potency and extent of inhibition, other combinations examined suggested that TMDT has a preference for β3 over β2 containing receptors. Lowest affinities were observed for β1-containing receptors. This differential sensitivity of β3 over β1 containing receptors is also shared by the insecticides, endosulfan, lindane, and fipronil . Interestingly, the extent of inhibition by TMDT was incomplete and ranged from 46 to 85%; addition of fipronil to the chambers could complete the inhibition of the GABA-evoked chloride current. Lowest IC50s (~0.5 μM) were seen against α2β3γ2L and the cerebellar-localized, benzodiazepine-insensitive α6β3γ2L receptor. In general TMDT displayed a greater range of receptor variant affinity than did picrotoxinin. While the receptors examined represent a fraction of the likely naturally occurring variants, the work serves to elucidate differences in TMDT and picrotoxinin affinities that may have toxicological relevance. These characteristics could influence (a) activity in discrete brain regions, (b) relative inhibition of synaptic vs. extrasynaptic GABA A receptors and (c) impact in different developmental stages.
A further examination of the selectivity of PTX and TMDT, as well as other agents, for human GABA A receptor subtypes was performed by Nik et al. (2017) . Using human HEK293 cells transfected to express the β3 homopentamer or the α1β3γ2 receptor, and mouse L-tk cells expressing the α4β3δ receptor, the investigators used a membrane potential sensitive dye, DiSBAC 1 (3) to measure GABA A -receptor dependent changes by agonists and antagonists. Current clamp experiments demonstrated that the fluorescent dye itself, a bis thiobarbiturate analogue, activated GABA A -receptor expressing cells, but not null cells. The authors took advantage of this feature and determined the effect of GABA A receptor channel blockers on the dye-induced fluorescent signal. PTX equivalently inhibited fluorescence of cells expressing α4β3δ and α1β3γ2 receptors (IC 50~6 μM, representing extrasynaptic and synaptic GABA A receptor variants respectively), while being 3-fold more potent in cells expressing the β3 pentamer, (most closely related to the insect GABA receptor, RDL, mentioned above). TMDT most potently inhibited fluorescence in cells expressing α1β3γ2 (IC 50 potently inhibited fluorescence in cells expressing~4 μM), was equivalent to PTX in those expressing α4β3δ, and one-fifth as potent as PTX in those expressing the β3 pentamer. The insecticide fipronil very potently inhibited the DiSBAC 1 (3) fluorescent signal in β3 pentamer and α4β3δ expressing cells (IC 50 = 0.2-0.25 μM), while being a 10-fold less potent inhibitor of α1β3γ2 expressing cells. These results demonstrated the variations in selectivity of the three agents, with PTX and fipronil having highest affinity, and TMDT, the lowest affinity, for the β3 pentamer.
Reexamination of TMDT action in vivo
In the light of numerous incidents of TMDT poisoning in recent years and recognition of its potential as a weapon of terror, new investigations have focused upon better understanding the syndrome it produces and identifying treatment modalities with the potential to both save lives and reduce long term morbidity of exposed individuals.
Characterization of the TMDT syndrome
Several investigators have published studies confirming and extending earlier reports, examining various endpoints and routes of exposure to TMDT, primarily in adult male rodents. Mice administered 0.1 to 0.5 mg/kg TMDT intraperitoneally (ip) exhibited a consistent pattern of behaviors (Shakarjian et al., 2012; Zolkowska et al., 2012) . The initial behavioral change, occurring within the first three minutes, was a freezing behavior, and cessation of locomotor activity (these are likely behavioral expressions of non-convulsive seizures). This was followed by twitches of the body and an erect and upright (Straub-like) tail, first signs of convulsive activity. Multiple twitches gave way to unilateral or bilateral clonic seizures consisting of forelimb clonus with rearing, with righting reflex preserved. One or several clonic seizures occurred after which a tonic-clonic seizure evolved. This consisted of a wild run, loss of righting reflex, tonic flexion of forelimbs and tonic flexion/extension of hindlimbs followed by clonic movements of all the limbs. If this seizure did not result in lethality, the subject recovered in a couple minutes. The animal could experience several tonic-clonic seizures before it eventually succumbed to or escaped the lethal consequences of this agent. At higher doses, a more rapid progression of the syndrome occurred, associated with fewer clonic and tonic-clonic seizures, and a higher probability of death. Interestingly, a comparison of the actions of TMDT and PTX by two different routes reveals that TMDT is 5-fold more potent than PTX in precipitating seizures after iv administration whereas this potency differential disappears after intraventricular administration of the agents (Zolkowska et al., 2012) . These results suggest that a greater rate of disposition and/or slower rate of partitioning into the brain by PTX could explain the relative activities of these two agents as a function of administration route (Soto-Otero et al., 1989) .
In an alternate approach for exposure, detection and quantification of TMDT action, Rice et al. (2017) used an operant behavioral model after oral exposure of adult male rats to the poison. Subjects were trained on a variable interval reinforcement schedule for food pellets. The dosage form employed was a breakfast cereal morsel adulterated with TMDT, offered prior to the operant task. Performance was greatly affected by TMDT exposure and served as a sensitive indicator of intoxication. Changes in the rate of lever pressing and food pellets earned were the most sensitive indicators, allowing detection of TMDT doses as low as 0.04 mg/kg. The investigators also noted piloerection, hunched posture, and exaggerated responses to auditory or tactile stimuli as consistent symptoms of TMDT poisoning. The 24 h LD50 for their oral dosage form was 0.29 mg/kg, similar to that reported by Zolkowska et al. (2012) for oral gavage in mice.
Further examination of the effect of mode of administration on TMDT toxicity was reported by Laukova and colleagues (2019) , in which two oral dosage forms, cereal morsel and peanut butter pellet, were compared with i.p. and s.c. parenteral routes in adult male mice. Onset of action of TMDT administered via cereal was surprisingly fast, in some cases equivalent to i.p. administration, while considerably delayed in those subjects exposed via peanut butter pellet. The rank order of potency as a function of mode of administration was i.p. > s.c. ≥ oral cereal > > oral peanut butter. It is suggested that the fat content of peanut butter may interfere with efficient enteral TMDT absorption. This finding is relevant to the predominant exposure of TMDT via adulterated food and drink and illustrates the importance of food composition as a variable in poisoning. Laukova et al. (2018) extended investigations to the examination of vulnerable populations, comparing the neurotoxic actions of TMDT in adult male rats to juveniles and females. Male and female subjects of postnatal day 15 (P15), 25 (P25) and adult ages (> P60) were exposed to TMDT by s.c. administration. Sensitivity to TMDT varied as a function of age with P15 animals having half-maximal convulsive and lethal doses at least one half-log lower than that for adults. This was reflected in overall severity scores as indicated in Fig. 2 . Seizures were also of a longer duration than observed in adults. In contrast, P25 subjects were only slightly more sensitive than the adults, suggesting an important developmental change affecting TMDT toxicity within the 10 days that separate these two developmentally different groups. One striking symptom not previously reported in rodent studies of TMDT toxicity was the presence of barrel rotations (Fig. 3) , defined as fast turning along the animal's longitudinal axis, during seizures. These were observed in P25 and adult subjects of both sexes. Differences in TMDT toxicity as a function of sex were more subtle, but suggested greater susceptibility of females. Three significant examples included the greater number of clonic seizures in P15, more numerous barrel rotations in P25 (Fig. 3) , as well as the more rapid onset to clonic seizures in adult females as compared to males. A challenge of those P15 and adult subjects who survived for 7 days following TMDT exposure, with the volatile convulsant agent flurothyl, revealed an elevated clonic, but not tonic-clonic seizure threshold relative to control animals. This demonstrates that adaptive mechanisms are being invoked by acute exposure to this potent neurotoxin.
Exposure in vulnerable populations

Electrocorticographic (ECoG) changes
Changes in cortical electroencephalographic (EEG) pattern accompany TMDT-induced behavioral seizures in rodents. These EEG changes are quite typical and loosely reflect the phenotype of myoclonic jerks, clonic seizures, and tonic-clonic seizures seen in behavior. Sobotka and Safanda (1973) and Dray (1975) both provided descriptions of TMDTinduced alterations in cortical EEG in anesthetized rats, observing high amplitude spiking upon i.v. infusion or direct cortical application of the substance. We documented the relation between ECoG and behavioral seizure phenotype in freely moving adult mice as well as in P15 and adult rats after exposure to TMDT with or without administration of potential countermeasures (Shakarjian et al., 2012) . Low-amplitude cortical EEG activity in the naive animal (baseline EEG) converted to synchronized, high-amplitude discharges occurring shortly after administration of TMDT (0.3 mg/kg for P15, 0.6 mg/kg for adult rats, sc, Fig. 4) . Polyspike, and spike and wave activity followed (associated with immobility/freezing) and preceded occurrence of a clonic motor seizure. These data suggest that the onset of TMDT-induced seizures is likely within the cortical network (Shakarjian et al., 2012) . Indeed clonic motor seizures (see the parts of the TMDT syndrome above) were regularly associated with polyspike-or spike-and-wave ECoG activity supporting their forebrain character. Later, spike and wave discharges of lower amplitude occurred, indicative of, and following several seconds after the observation of a tonic-clonic seizure. The delay in cortical EEG activity relative to the behavioral signs of a tonic-clonic seizure, together with the fact that TMDT-induced seizures occur in decerebrate animals, suggest that the origin of this type of seizure is within the brain stem structures (Browning and Nelson, 1986; Haskell and Voss, 1957) . Human clinical cases of TMDT poisoning have reported similar paroxysmal high amplitude unilateral and bilateral ictal activity with generalized spike and slow wave discharges (Chau et al., 2005; Li et al., 2012; Lu et al., 2008) .
Examination of potential countermeasures
In vitro and rapid screening tools
Methods to measure GABA A receptor-operated Cl − channel activity have included use of 36 Cl − as a tracer to ascertain chloride flux through the ion channel (Galofre et al., 2010; Huang and Casida, 1996) , and/or by monitoring GABA A receptor-dependent intracellular acidification with a pH sensitive fluorescent dye as a surrogate for Cl − entry (Simpson et al., 2000) . In contrast, monitoring changes in neuronal excitability downstream from the GABA A receptor complex, such as Ca 2+ influx, allows one to test agents having a variety of mechanisms of action against consequences of GABA A receptor blockade. This method was selected by Cao and colleagues for the purposes of screening compounds as potential countermeasures of TMDT poisoning (Cao et al., 2012) . Dissociated hippocampal cell cultures from newborn mice, grown for 13-17 days in vitro (DIV) exhibit spontaneous Ca 2+ oscillations, as measured by Ca 2+ -sensitive fluorescent dye (Cao et al., 2012) .
These oscillations are antagonized by the voltage sensitive Na + channel blocker, tetrodotoxin, indicating that they are dependent upon neuronal depolarization (Cao et al., 2017 grown for 14-16 DIV, are also being applied to identify potential treatments for TMDT exposure . In this model, the NMDA receptor antagonists, MK-801 and ketamine, have been found to display a more persistent antagonistic effect upon TMDT action than that seen with DZP . A potential in vivo rapid screening tool under exploration involves the use of larval Zebrafish (Danio rerio) (Bandara et al., 2016) . Unlike insects, GABA A receptors of teleost fish are heteropentamers more akin to that found in mammals (Bahn et al., 1996; Delgado and Schmachtenberg, 2008; Renier et al., 2007) . They express eight α and four ß subunits, compared to six α and three ß subunits found in mammals, with no θ or ε subunits. Amino acid identities with the corresponding rodent GABA A subunits range from 53% to 86% (Monesson-Olson et al., 2018) . The organism's small size, responsiveness to a variety of convulsant agents, and the availability of automated methods of assessment, make them a potentially useful and relevant model to screen for TMDT countermeasures.
Testing countermeasures using in vivo rodent models
In humans, a wide variety of anticonvulsant agents have been administered, singly, or often in succession, to control generalized seizures produced by TMDT exposure. In addition to gastric lavage for removing TMDT from the stomach (Deng et al., 2012) , pharmacotherapy is necessary to control actions of the poison already absorbed. Extracorporeal blood purification is also used to decrease the duration of severe poisonings (Chau et al., 2005; Gong et al., 2006) . Regarding pharmacotherapy, the list of agents administered includes benzodiazepines, barbiturates, diphenylhydantoin, valproate, carbamazepine, topiramate, and ketamine, with polytherapy often needed for complete seizure control (Chau et al., 2005; Croddy, 2004) . There are also reports that pyridoxine and dimercaptopropanesulfonate can be useful as treatments (Chau et al., 2005; Croddy, 2004) .
Given the common use of benzodiazepines in the treatment of status epilepticus, (Flomenbaum et al., 2006; Ochoa and Kilgo, 2016) and our experience using NMDA receptor antagonists as antiseizure agents (Velíšek and Mareš, 1992; Velíšek et al., 1991; Velíšková and Velíšek, 1992; Velíšková et al., 1990) , we examined the ability of DZP, ketamine, and MK-801, administered ip, to control seizures and reduce lethality in mice exposed to TMDT. We found that a 15 min pretreatment with these agents prior to exposure to TMDT, and posttreatment immediately following the first TMDT-induced clonic seizure, exhibited roughly equivalent effectiveness in controlling seizures and preventing short-term lethality (Shakarjian et al., 2012) . These actions were dosedependent, with higher doses of these agents all providing significant, but not complete protection of the subjects. In the case of ketamine (70 mg/kg) and MK-801 (1 mg/kg), subjects were protected from tonicclonic seizures and lethality, but clonic seizures were poorly controlled. On the other hand, DZP (5 mg/kg) effectively suppressed clonic and tonic-clonic seizures at early time points, however was unable to eliminate the abnormal electrographic activity produced by TMDT and these animals were more likely to succumb to TMDT's lethal effects hours later. We subsequently administered a 3:1 fixed ratio of the DZP:MK-801 combination in a broad range of doses in order to take advantage of the most positive aspects of each of these agents as treatments. Simultaneous administration of DZP and MK-801 produced synergistic protection against tonic-clonic seizures and 24-h lethality in TMDT-exposed mice, as determined by isobolographic analysis (Fig. 5 ) (Gessner, 1995; Shakarjian et al., 2015) . However, clonic seizures remained poorly controlled. A change to a sequential therapeutic regimen where MK-801 was administered 10 min after DZP treatment, further improved the outcome, with good control of clonic seizures and reduction of overall severity of the syndrome relative to the simultaneous administration of the agents (Fig. 6 ). This work suggests that Fig. 4 . Representative image of EEG recordings from P15 (A) and adult rat (B) administered with TMDT (0.3 mg/kg for P15, 0.6 mg/kg for the adult). Upper panels display a typical baseline EEG for an awake state prior to administration of TMDT. Three channels were recorded simultaneously. LF and RO (signals from the left frontal and right occipital cortices) were recorded in unipolar mode (each versus reference electrode). The signal from right frontal (RF) and left occipital (LO) cortices was recorded as bipolar RF-LO. Synchronous EEG discharges of spike-and-wave character associated behaviorally with whole body twitches (a). Typical EEG recordings during a clonic seizure. Individual high-amplitude discharges preceded the occurrence of the clonic seizure, after which multiple spikes and spike-andwave complexes developed. Clonic motor seizure started at the arrow (b). From a preceding clonic seizure, the rat progressed to a tonic-clonic seizure (arrow (c)). The arrow points to the onset of wild run followed by a fall during the tonic phase of the seizure and a long clonus of all four limbs exceeding the duration of this sample recording associated with relatively low-amplitude spike-and-wave rhythm. (calibrations in μV, time mark 1 s). From Laukova et al. (2018) . combination benzodiazepine-NMDA receptor antagonist regimens with sequential administration may constitute an effective pharmacotherapy to counteract TMDT poisoning. Indeed, alterations in receptor dynamics following seizure onset in the lithium-pilocarpine model provide a rationale for combination therapies and experimental evidence supports their use (Niquet et al., 2017) .
Choosing agents based upon their in vitro investigations (Cao et al., 2012) , Bruun et al. (2015) , examined the ability of DZP, the neurosteroid allopregnanolone, and their combinations to antagonize seizures and lethality produced by TMDT exposure. They found, in both pre-(10 min prior to TMDT administration) and posttreatment (2 min after the second clonic seizure) paradigms, that a subthreshold, or partially effective dose of each agent (0.03 mg/kg ip) when administered simultaneously, achieved an improved 24-h survival, relative to either agent administered singly. They also observed increases in astrogliosis as evidenced by GFAP immunoreactivity, and decreases in microglial activation, in the cerebral cortex and hippocampus of mice treated with this combination within 72 h post-TMDT exposure, relative to high dose DZP (5 mg/kg)-treated, TMDT-exposed mice. There are several ways in which benzodiazepines and neurosteroids may complement each other. While they both have binding sites on GABA A -receptor ionophore complexes, benzodiazepines primarily interact with receptors in the synaptic cleft, whereas neurosteroids bind these synaptic receptors as well as extrasynaptic receptors, where they may more effectively modulate GABA action (Brickley and Mody, 2012) . The mode of allosteric modification differs for these two agent classes as well. Finally, there is evidence that when bound to the same complex, neurosteroids can increase the binding affinity of benzodiazepines (Hawkinson et al., 1994) . These reasons provide a sound basis for considering benzodiazepine-neurosteroid combinations for the antagonism of GABA channel blockers. Beyond their complementary nature with benzodiazepines, neurosteroids may have specific advantages over the latter agents given their ability to act as both GABA allosteric modulators as well as direct activators of GABA A channels, and experimental evidence that they are effective in seizures refractory to benzodiazepines. These features prompted Zolkowska and colleagues to compare the effectiveness of two neurosteroids, allopregnanolone and ganaxolone, in a mouse model of status epilepticus (SE) considered relatively resistant to benzodiazepines (Zolkowska et al., 2018) . This model employed TMDT (0.2 mg/kg) combined with riluzole (10 mg/ kg), an agent which, when administered 10 min prior to TMDT, inhibits lethal tonic-clonic seizures, and rather produces a protracted seizure syndrome analogous to SE. The neurosteroids allopregnanolone or ganaxolone were administered at 3 mg/kg intramuscularly, 40 min after the first TMDT-induced myoclonic twitch. Of the two agents, allopregnanolone showed greater effectiveness, halting seizures more than twice as quickly as ganaxolone, and resulting in 85% vs 50% survival of the subjects at 72 h, respectively. Measurement of blood and brain levels of the two agents indicated that allopregnanolone reached approximate maximum brain concentration level (Tmax) at 5 min, while ganaxolone levels continued to rise, reaching Tmax at 10 min and remaining above allopregnanolone levels for the remainder of the 2-h sampling duration. The results indicate that ganaxolone is less potent than allopregnanolone in this model. Inceoglu et al. (2013) reported that inhibitors of soluble epoxide hydrolase, an enzyme that degrades epoxyeicosatrienoic acids, can modify the actions of GABA A receptor complex antagonists pentylenetetrazole and PTX, increasing latency and preventing tonic seizure activity. Conversely, these agents were ineffective against seizures produced by either maximal electroshock or the voltage-gated K + channel blocker 4-aminopyridine. A more recent study by this group (Vito et al., 2014) demonstrated that pretreatment with the soluble epoxide hydrolase inhibitor, TUPS, could prevent TMDT-induced tonic-clonic seizures and lethality. Unfortunately, this agent was not active in a postexposure paradigm, however the results of these studies suggest that endogenous physiological antiseizure molecules may be generated upon GABA A receptor blockade.
Conclusions, insight, and future directions
The thousands of serious poisonings produced by inadvertent and intentional TMDT exposure underscore the urgency for more effectively controlling its availability while also characterizing the syndrome it produces and devising the best treatments for acute and long term Fig. 5 . Isobologram for the interaction DZP and MK-801 in suppressing TMDTinduced tonic-clonic seizures in mice. ED50s ± 95% CI of DZP (downwards triangle) and MK-801 (upwards triangle) administered singly were plotted on the x and y axes, respectively. The line of additivity connects these ED50s. Open circles: Theoretical ED50 ± 95% CI for inhibition of tonic-clonic seizures by DZP:MK-801 3:1. Closed circles: actual ED50 ± 95% CI of the DZP:MK-801 3:1 combination. This dose was significantly below the theoretical point of additivity (p < .006). Dotted lines: depict the 3:1 and 11:1 DZP:MK-801 fixed ratios. Treatment with the predicted ED50 dose for the DZP:MK-801 11:1 combination yielded greater inhibitory activity than expected, suggesting that synergy observed by these two agents is not isolated to their 3:1 combination. From Shakarjian et al. (2015) . was administered 10 min after DZP administration. This latter regimen provided a significantly improved severity score relative to simultaneous administration of DZP and MK-801 (p = .0013, Mann-Whitney U Test). From Shakarjian et al. (2015) .
toxicity. From the research performed in recent years in rodent models, we now have a better understanding of the phenotypic and corresponding electrographic features of the neurotoxic syndrome produced by TMDT, the influence of mode of administration, of age and sex, and some of the neuropathological features. Furthermore, in vitro methods have been developed and validated to screen for effective treatments, while also providing important information regarding cellular mechanisms of TMDT action. Additionally, we have a grasp of the variations in affinity TMDT displays for individual species of the heterogeneous population of GABA A -receptors expressed in mammals. While TMDT shares many toxicological characteristics with the various families of GABA A receptor blockers such as the naturally occurring sesquiterpene lactones (e.g., PTX and tutin) and the synthetic bicyclophosphorous and organochlorine insecticides, it also displays unique properties, due to its potency, physicochemical properties, and those characteristics that place it in the category of a chemical threat agent (Jett and Yeung, 2010) .
One example of where TMDT may depart from other GABA A receptor blockers regards the ability to cause chemical kindling, i.e., a long lasting decrease in seizure threshold after repeated administration of subconvulsant doses of a convulsant agent, considered to be an epileptogenic process characteristic of this toxicological class (Gilbert and Goodman, 2006) . An attempt at TMDT-induced kindling using a treatment regimen demonstrable with pentylenetetrazole was not successful (Zolkowska et al., 2012) . This could be due to the inability of this agent, from a pharmacodynamic perspective, to activate the necessary anatomic pathways to alter seizure threshold and intensity. Alternatively and very likely, this could be a pharmacokinetic issue, given its persistence in the body, as proper interstimulus intervals are essential for both electrical and chemical kindling (Racine et al., 1973) . Further study of the question of TMDT and kindling may be important in better understanding the long term aspects of TMDT poisoning in its human victims.
As unfortunate as it is, TMDT neurotoxicology also contributes to our understanding of epileptogenesis. Deng et al. (2012) , found that over 50% of TMDT poisoning victims in their study had delayed recurrent seizures without any immediate trigger, i.e., epilepsy. They presented two cohorts of TMDT-exposed patients: In an untreated cohort, 16 out of 17 patients had no initial (clinical) seizures and all 17 received no medication. The outcome was epilepsy in 100% of cases. The second, treated cohort of 353 total patients, included 351 patients with initial seizures. In this cohort, all patients were treated with sodium valproate (those with status epilepticus also received i.v. diazepam) and epilepsy occurrence was only 55%. Of those patients who acquired epilepsy, the majority (~80%) displayed tonic-clonic, i.e., generalized seizures. As a conclusion, TMDT is a powerful epileptogenic agent in humans and aggressive treatment after the initial precipitating event can ameliorate the outcome. In the case of rodents, TMDT may not be so powerful in creating epileptogenesis because first, it does not readily provide a kindling effect even with 2-day interinjection interval (see above and (Zolkowska et al., 2012) ) and second, while status epilepticus is a common trigger of epileptogenesis in rodents (Haut et al., 2004; Pitkanen et al., 2015) , TMDT-induced prolonged seizures that resemble status epilepticus are almost always lethal. However, in humans, TMDT may utilize another mechanism of initial precipitating injury since epilepsy developed also in those victims of TMDT poisoning who did not experience acute seizures (or had undetected subclinical seizures) (Deng et al., 2012) . In any case, immediate, aggressive and long-term treatment of initial seizures appears to be warranted to decrease the likelihood of an epileptogenic outcome after TMDT exposure (Deng et al., 2012) .
Likewise, despite the numerous clinical cases demonstrating the protracted neurological effects of TMDT, (again, including those who did not experience severe acute symptoms) (Chau et al., 2005; Deng et al., 2012; Lu et al., 2008) , the animal models currently applied have demonstrated little in terms of neuronopathy or delayed behavioral changes. Evidence, via Fluoro-Jade staining, of neuronal death or cell loss was observed neither in the brains of adult mice 4 h to 7 days after exposure to doses of TMDT producing clonic seizures (Zolkowska et al., 2012) nor in P15, P25, or adult rats 24 h after exposure to TMDT doses that produced tonic-clonic seizures (Laukova et al., 2018) . Rather, a reactive gliosis has been documented involving astroglia and microglia (Zolkowska et al., 2012) (without obvious presence of cell death), which may represent both protective and destructive responses to the poison as suggested by the influences of GABA A positive allosteric modulators on these changes Vito et al., 2014) .
In regard to behavioral changes, efforts to identify significant, persistent alterations in response to TMDT have not been fruitful thus far. In a study subjecting mice to anxiety, depression, memory, and locomotor assessments at 7, 30, and 60 days after exposure to a TMDT dose producing clonic seizures, only vertical locomotor activity in the 60 day group showed any significant change relative to untreated animals (Flannery et al., 2015) . Lack of prolonged seizure activity, the use of a rescue agent (DZP) to prevent death, behavioral tests chosen, or species and strain are some explanations for why behavioral sequelae have not been observed. Thus, there are opportunities for new models or further refinement of current models to better reflect features seen in clinical cases.
Our understanding of age-and sex-related differences in influencing susceptibility to the TMDT-induced syndrome should also significantly improve. Reports from China indicate that males and females are equally likely to be victims of pesticide poisonings. Furthermore, one study suggests that roughly one-third of all victims of pesticide poisonings in China are young children from 8 months to 4 years of age (Chen et al., 2005) , and certainly there are ample instances where children have been targeted in intentional poisoning attempts with TMDT ("kindergarten wars"). It should be emphasized here that in the largest reported poisoning by TMDT in China, all deadly cases were children (Croddy, 2004; Li et al., 2014; Wu and Sun, 2004) , supporting our notion that the immature brain is significantly more sensitive to toxic effects of TMDT compared to the adult brain. Indeed, our studies (Laukova et al., 2018) indicate that postnatal day 15 rats are much more sensitive to TMDT as compared to adults or even 25 day old animals (Fig. 2) . Our preliminary data suggest that response to treatments also appears to differ as a function of age .
Also clearly needed is an understanding of the toxicokinetics of TMDT, at least from oral exposure, the most common poisoning route. Very little is known regarding the absorption, distribution, metabolism, and excretion of TMDT. Reports from China, using various means to extract TMDT from blood as an important mode of detoxification (hemoperfusion and hemofiltration) found blood levels to initially drop, and then rebound (Chau et al., 2005; Gong et al., 2006) . This suggests that TMDT persists in certain tissues in primarily unchanged form for long periods of time. In a study with orally administered 14 C-TMDT radiotracer, Radwan and Dodge (1970) found that rapid but apparently incomplete absorption from the GI tract occurred, followed by efficient distribution to the major organs and nearly complete excretion by 72 h. Radioactivity was found in feces, urine, and expired air. A metabolite, more hydrophobic than the parent, was observed from extracts of certain tissues, migrating chromatographically with a synthetic impurity. In a similar experiment with snowshoe hares, they reported essentially the same result as that seen in mice. More recently, however, Zhang et al. (2005) had findings somewhat at variance with that of Radwan and Dodge. They exposed rabbits to TMDT via i.v. and oral routes, and analyzed samples by GC with nitrogen-phosphorous detection. Halflives of TMDT elimination were 57 h for the i.v. and 262 h for the oral route. Elimination was primarily via the urine with < 20% of TMDT excreted in the bile. Administration of activated charcoal immediately after TMDT exposure shortened elimination half-life by 55% after oral intake. Further information on the absorption and disposition of TMDT is important in correlating tissue levels with toxic signs and for determining the optimal duration of treatment with countermeasures. A recent immunometric method shows promise in providing sensitive quantification of tissue TMDT concentrations in a rapid format (Barnych et al., 2017) . In regard to medical countermeasures for TMDT poisoning, in vitro and in vivo screening have provided a finite number of promising treatments which have thus far fallen into three categories: benzodiazepines, neurosteroids, and NMDA receptor antagonists. Two-drug combinations, selected from different groups of agents (benzodiazepines-neurosteroids; benzodiazepines-NMDA receptor antagonists) constitute the most promising treatment leads. With our increasing understanding of the cellular and molecular events initiated by TMDT, as well as the screening models and methods now available, it is hoped that improved treatments will be devised that manage the acute syndrome and address long-term consequences of TMDT poisoning as well.
